Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitis
- 30 November 2004
- journal article
- clinical trial
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 93 (5) , 425-430
- https://doi.org/10.1016/s1081-1206(10)61408-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Noninjection routes for immunotherapyJournal of Allergy and Clinical Immunology, 2003
- Long‐lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10‐year prospective studyClinical and Experimental Allergy, 2003
- Safety of Allergen-Specific Sublingual Immunotherapy and Nasal ImmunotherapyPublished by S. Karger AG ,2003
- Is sublingual immunotherapy clinically effective?Current Opinion in Allergy and Clinical Immunology, 2002
- Clinical and immunologic effects of long‐term sublingual immunotherapy in asthmatic children sensitized to mites:a double‐blind, placebo‐controlled studyAllergy, 2000
- Safety of Sublingual-Swallow Immunotherapy in Children and AdultsInternational Archives of Allergy and Immunology, 2000
- Sublingual immunotherapy: a double‐blind, placebo‐controlled trial with Parietaria judaica extract standardized in mass units in patients with rhinoconjunctivitis, asthma, or bothAllergy, 1999
- Immunotherapy as an effective tool in allergy treatmentAllergy, 1998
- A double‐blind, placebo‐controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extractAllergy, 1994
- PROPHYLACTIC INOCULATION AGAINST HAY FEVERPublished by Elsevier ,1911